SURG vs ATEX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

SURG

43.7
AI Score
VS
ATEX Wins

ATEX

50.4
AI Score

Investment Advisor Scores

SURG

44score
Recommendation
HOLD

ATEX

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SURG ATEX Winner
Revenue 32.19M 1.96M SURG
Net Income -10.76M 240,000 ATEX
Net Margin -33.4% 12.3% ATEX
Operating Income -7.75M -246,000 ATEX
ROE 52.0% 0.1% SURG
ROA -116.5% 0.0% ATEX
Total Assets 9.24M 497.93M ATEX
Cash 1.95M 116.01M ATEX
Current Ratio 0.19 4.85 ATEX

Relative Price Performance (Last 90 Days)

SURG 1M: -8.6% · 3M: -60.2% ATEX 1M: -2.0% · 3M: +8.6%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.4%), weak momentum, RSI 41

RSI (14): 41.1 · Price: $0.16

ATEX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.9 · Price: $83.62

Fundamentals Snapshot

Metric SURG ATEX
Market Cap
Forward P/E 16.0 -63.0
Trailing P/E 22.1
Revenue (TTM)
Revenue Growth 0.4% 0.4%
Gross Margin -0.2% 1.0%
Operating Margin 0.2% -5.6%
EPS -1.49 3.49
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ATEX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.